Jiangsu Hansoh Pharmaceutical Group Competitors and Similar CompaniesClear all

Jiangsu Hansoh Pharmaceutical Group's competitors and similar companies include CureVac.
Jiangsu Hansoh Pharmaceutical Group
Jiangsu Hansoh Pharmaceutical Group
Jiangsu Hansoh Pharmaceutical Group is a pharmaceutical company.
CureVac
CureVac
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
Founding Date
Founding Date
1995
Founding Date
2000
Type
Type
Public
Type
Public
Tags
Locations
Locations
Lianyungang Shi, CN HQ
Locations
Tübingen, DE HQ
Ottignies Louvain La Neuve, BE
Wiesbaden, DE
Amsterdam, NL
Basel, CH
Boston, US
Employees
Employees
9,099
Employees
999

Financial

Revenue (est.)
Revenue (est.)
¥10.1b (FY, 2023)
Revenue (est.)
€53.8m (FY, 2023)
Cost of goods
Cost of goods
¥664.5m (FY, 2023)
Cost of goods
€64.3m (FY, 2023)
Gross profit
Gross profit
¥9.5b (FY, 2023)
Gross profit
(€2.6m) (FY, 2023)
Net income
Net income
¥3.3b (FY, 2023)
Net income
(€260.2m) (FY, 2023)
For sources of this data, please see the company profile

View Company Profiles

CureVac
HQ
Tübingen, DE
Employees
999

CureVac is a biotechnology company offering messenger RNA (mRNA) technology.

View company